High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype
- PMID: 17977954
- DOI: 10.2337/db07-0932
High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype
Abstract
Objective: To explore whether an imbalance between the visceral and subcutaneous fat depots and a corresponding dysregulation of the adipokine milieu is associated with excessive accumulation of fat in the liver and muscle and ultimately with insulin resistance and the metabolic syndrome.
Research design and methods: We stratified our multi-ethnic cohort of 118 obese adolescents into tertiles based on the proportion of abdominal fat in the visceral depot. Abdominal and liver fat were measured by magnetic resonance imaging and muscle lipid (intramyocellular lipid) by proton magnetic resonance spectroscopy.
Results: There were no differences in age, BMI Z score, or fat-free mass across tertiles. However, as the proportion of visceral fat increased across tertiles, BMI and percentage of fat and subcutaneous fat decreased, while hepatic fat increased. In addition, there was an increase in 2-h glucose, insulin, c-peptide, triglyceride levels, and insulin resistance. Notably, both leptin and total adiponectin were significantly lower in tertile 3 than 1, while C-reactive protein and interleukin-6 were not different across tertiles. There was a significant increase in the odds ratio for the metabolic syndrome, with subjects in tertile 3 5.2 times more likely to have the metabolic syndrome than those in tertile 1.
Conclusions: Obese adolescents with a high proportion of visceral fat and relatively low abdominal subcutaneous fat have a phenotype reminiscent of partial lipodystrophy. These adolescents are not necessarily the most severely obese, yet they suffer from severe metabolic complications and are at a high risk of having the metabolic syndrome.
Similar articles
-
Ectopic fat deposition and the metabolic syndrome in obese children and adolescents.Horm Res. 2009 Jan;71 Suppl 1:2-7. doi: 10.1159/000178028. Epub 2009 Jan 21. Horm Res. 2009. PMID: 19153496
-
High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.Diabetes Care. 2007 May;30(5):1173-8. doi: 10.2337/dc06-2342. Epub 2007 Jan 26. Diabetes Care. 2007. PMID: 17259477
-
Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.Ann Med. 2009;41(2):152-60. doi: 10.1080/07853890802446754. Ann Med. 2009. PMID: 18855190
-
Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.Horm Metab Res. 2002 Nov-Dec;34(11-12):616-21. doi: 10.1055/s-2002-38256. Horm Metab Res. 2002. PMID: 12660870 Review.
-
[Metabolic difference between visceral fat and subcutaneous abdominal fat].Diabetes Metab. 2000 Jun;26 Suppl 3:10-2. Diabetes Metab. 2000. PMID: 10945144 Review. French.
Cited by
-
Childhood obesity and the associated rise in cardiometabolic complications.Nat Metab. 2020 Mar;2(3):223-232. doi: 10.1038/s42255-020-0183-z. Epub 2020 Mar 16. Nat Metab. 2020. PMID: 32694781 Free PMC article. Review.
-
Development of associations among central adiposity, adiponectin and insulin sensitivity from adolescence to young adulthood.Diabet Med. 2012 Sep;29(9):1153-8. doi: 10.1111/j.1464-5491.2012.03726.x. Diabet Med. 2012. PMID: 22672197 Free PMC article.
-
Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.Diabetes Care. 2010 Aug;33(8):1817-22. doi: 10.2337/dc10-0284. Diabetes Care. 2010. PMID: 20668154 Free PMC article.
-
A novel evaluation of density differences in subcutaneous abdominal adipose tissue layers in pregnancy using elastography.Australas J Ultrasound Med. 2018 Jun 25;21(4):227-233. doi: 10.1002/ajum.12100. eCollection 2018 Nov. Australas J Ultrasound Med. 2018. PMID: 34760527 Free PMC article.
-
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?Am J Cardiovasc Drugs. 2016 Aug;16(4):255-266. doi: 10.1007/s40256-016-0165-4. Am J Cardiovasc Drugs. 2016. PMID: 26940560 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials